MedPath

Trauma-focused therapy in people at risk of psychosis

Not Applicable
Completed
Conditions
Psychosis
Mental and Behavioural Disorders
Unspecified organic or symptomatic mental disorder
Registration Number
ISRCTN31976295
Lead Sponsor
niversity of Bristol
Brief Summary

2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33004398/ protocol (added 07/10/2020) 2024 Results article in https://doi.org/10.1192/bjo.2024.57 (added 25/06/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
14
Inclusion Criteria

1. Those aged 16 years or over who are at risk of psychosis (as defined in the Comprehensive Assessment of At-Risk Mental States (CAARMS) (A. R. Yung et al., 2005)
2. Presence of at least one positive symptom (perceptual abnormality, unusual thought, or non-bizarre ideas) scored =3 on CAARMS
3. History of traumatic experience as defined in ICD-10 F43.1, occurring prior to onset of first positive symptom
4. Presence of 1 or more symptoms of re-living, avoidance, hyper-arousal, or cognitive distortions in relation to the traumatic experience (assessed using the PTSD Checklist for DSM-V (PCL5) during the last month (Bovin et al., 2016))

Exclusion Criteria

1. People with past history of treated or untreated psychotic illness or learning disability
2. Current use of antipsychotics
3. Currently receiving psychological therapy
4. Completed a trauma-focused psychological therapy in the last 2 years
5. Insufficient fluency in English
6. Lacking mental capacity to provide valid informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Transition to psychosis assessed at 12 months post-randomization from clinical records (measured as an ICD-10 diagnosis of psychosis) or, if patients have dropped out of the Early Intervention Services, researchers will invite participants for an appointment where, via the CAARMS, it will be established whether they transitioned to psychosis.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath